The Food and Drug Administration has approved the first 3D printed pill.

The medicine, Spritam (levetiracetam), helps to treat epilepsy. Previous levetiracetam tablets did not dissolve easily, but the new version boasts porous layers that make it easily dissolvable, according to a press release from the company, Aprecia Pharmaceuticals. A spokesperson for the FDA confirmed to the Associated Press that Spritam is the first 3D printed prescription tablet to gain approval.

Seizure medication is often too large and difficult to swallow—particularly for the elderly and children—making advances in 3D printing key for epileptics and other who suffer from seizures, according to the company.

“By combining 3DP technology with a highly-prescribed epilepsy treatment, SPRITAM is designed to fill a need for patients who struggle with their current medication experience,” said Don Wetherhold, Chief Executive Officer of Aprecia.

The pill would be the latest in a series of healthcare products that utilize 3D printing, including jaw replicas, dental implants, and hip replacements. Scientists are currently working to develop 3D printed tracheas and bones, ears, kidneys, and skin.

Get our Health Newsletter. Sign up to receive the latest health and science news, plus answers to wellness questions and expert tips. Please enter a valid email address. Sign Up Now Check the box if you do not wish to receive promotional offers via email from TIME. You can unsubscribe at any time. By signing up you are agreeing to our Terms of Use and Privacy Policy . This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. Thank you! For your security, we've sent a confirmation email to the address you entered. Click the link to confirm your subscription and begin receiving our newsletters. If you don't get the confirmation within 10 minutes, please check your spam folder.

Write to Tanya Basu at tanya.basu@time.com.